Literature DB >> 16495525

Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype.

Amanda E Ramer1, Yannick F Vanloubbeeck, Douglas E Jones.   

Abstract

C3HeB/FeJ mice challenged with Leishmania major develop a polarized Th1 response and subsequently heal, whereas Leishmania amazonensis challenge leads to chronic lesions with high parasite loads at 10 weeks postinfection. In this study, a comparison of draining lymph node cells from L. amazonensis- and L. major-infected mice at 10 weeks postinfection showed equivalent percentages of effector/memory phenotype CD44hi CD4+ T cells producing interleukin-2 (IL-2) and proliferating after antigen stimulation. However, these cells isolated from L. amazonensis-infected mice were not skewed toward either a Th1 or Th2 phenotype in vivo, as evidenced by their unbiased Th1/Th2 transcription factor mRNA profile. In vivo antigen stimulation with added IL-12 failed to enhance gamma interferon (IFN-gamma) production of CD4+ T cells from L. amazonensis-infected mice. Antigen stimulation of CD4+ T cells from L. amazonensis-infected mice in vitro in the presence of IL-12 resulted in production of only 10 to 15% of the IFN-gamma produced by T cells from L. major-infected mice under identical conditions. These results suggest that the CD4+ T-cell response during chronic L. amazonensis infection is limited during the transition from an early activated CD4+ T-cell population to an effector cell population and demonstrate that these T cells have an intrinsic defect beyond the presence or absence of IL-12 during antigen stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495525      PMCID: PMC1418674          DOI: 10.1128/IAI.74.3.1547-1554.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 2.  Mini-review: regulatory T cells and infection: suppression revisited.

Authors:  Hans-Willi Mittrücker; Stefan H E Kaufmann
Journal:  Eur J Immunol       Date:  2004-02       Impact factor: 5.532

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 4.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

5.  Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania.

Authors:  Ivana Nunes Gomes; Aknar Freire de Carvalho Calabrich; Rafael da Silva Tavares; Jeanne Wietzerbin; Luiz Antônio Rodrigues de Freitas; Patrícia Sampaio Tavares Veras
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

6.  Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

Authors:  Colby Zaph; Jude Uzonna; Stephen M Beverley; Phillip Scott
Journal:  Nat Med       Date:  2004-09-26       Impact factor: 53.440

7.  CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing.

Authors:  Yannick F Vanloubbeeck; Amanda E Ramer; Fei Jie; Douglas E Jones
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis.

Authors:  Jiaxiang Ji; Jiaren Sun; Lynn Soong
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  A spectrum in the susceptibility of leishmanial strains to intracellular killing by murine macrophages.

Authors:  P Scott; A Sher
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

10.  T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3.

Authors:  Habiba Chakir; Haiping Wang; David E Lefebvre; John Webb; Fraser W Scott
Journal:  J Immunol Methods       Date:  2003-07       Impact factor: 2.303

View more
  12 in total

1.  Promotion of a functional B cell germinal center response after Leishmania species co-infection is associated with lesion resolution.

Authors:  Katherine N Gibson-Corley; Paola M Boggiatto; Marie M Bockenstedt; Christine A Petersen; Thomas J Waldschmidt; Douglas E Jones
Journal:  Am J Pathol       Date:  2012-03-17       Impact factor: 4.307

2.  IL-2 limits IL-12 enhanced lymphocyte proliferation during Leishmania amazonensis infection.

Authors:  Amanda E Ramer-Tait; Christine A Petersen; Douglas E Jones
Journal:  Cell Immunol       Date:  2011-04-09       Impact factor: 4.868

3.  Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function.

Authors:  J L M Wanderley; P E Thorpe; M A Barcinski; L Soong
Journal:  Parasite Immunol       Date:  2013 Mar-Apr       Impact factor: 2.280

4.  A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis.

Authors:  Katherine N Gibson-Corley; Paola M Boggiatto; Rami M Mukbel; Christine A Petersen; Douglas E Jones
Journal:  Int J Parasitol       Date:  2009-12-11       Impact factor: 3.981

5.  Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold.

Authors:  Paola M Boggiatto; Pedro A Martinez; Ashok Pullikuth; Douglas E Jones; Bryan Bellaire; Andrew Catling; Christine Petersen
Journal:  Microbes Infect       Date:  2014-01-22       Impact factor: 2.700

6.  Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK.

Authors:  Paola Mercedes Boggiatto; Fei Jie; Mousumi Ghosh; Katherine Nicole Gibson-Corley; Amanda Ellen Ramer-Tait; Douglas Elliot Jones; Christine Anne Petersen
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

7.  Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo.

Authors:  Lijun Xin; Yongguo Li; Lynn Soong
Journal:  Infect Immun       Date:  2007-08-06       Impact factor: 3.441

Review 8.  Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms.

Authors:  Pedro A Martinez; Christine A Petersen
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

9.  A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.

Authors:  Yashdeep Phanse; Brenda R Carrillo-Conde; Amanda E Ramer-Tait; Scott Broderick; Chang Sun Kong; Krishna Rajan; Ramon Flick; Robert B Mandell; Balaji Narasimhan; Michael J Wannemuehler
Journal:  Sci Rep       Date:  2014-01-20       Impact factor: 4.379

10.  An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis.

Authors:  Katherine N Gibson-Corley; Marie M Bockenstedt; Huijuan Li; Paola M Boggiatto; Yashdeep Phanse; Christine A Petersen; Bryan H Bellaire; Douglas E Jones
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.